Times of India10h agoLaurus Labs Q2 net profit surges 126% on CDMO and affordable medicines growthRevenue rose 33% year over year to ₹2,206 crore. CDMO revenue climbed 75% over the same period. SourceDisclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.Stocks